Geron: A Post Earnings And Funding Announcement Assessment

Live Chat on The Biotech Forum has been dominated by discussion of lucrative buy-write or covered call opportunities on selected biotech stocks over the past several months. To see what I and the other season biotech investors are targeting as trading ideas real-time, just join our community at The Biotech Forum by clicking HERE .It has been a year and a half since my last look at an oncology name called Geron Corporation (NASDAQ: GERN ) . To understate things, it has been a busy and potentially transformat ...